Benazecare Flavour 20 mg Tablets for Dogs

Dogs:
Undetermined frequency
(cannot be estimated from the
available data):
Vomiting
Incoordination
Fatigue
Elevated creatinine
1
Transient
In dogs with chronic kidney disease, at the start of therapy. A moderate increase in
plasma creatinine concentrations following the administration of ACE inhibitors is
compatible with the reduction in glomerular hypertension induced by these agents
and is therefore not necessarily a reason to stop therapy in the absence of other
signs.
In double-blind clinical trials in dogs with congestive heart failure, benazepril
hydrochloride was well tolerated with an incidence of adverse reactions lower than
observed in placebo-treated dogs.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
either the marketing authorisation holder or its local representative or the national
competent authority via the national reporting system. See the package leaflet for
respective contact details.
AN: 02966/2024 & 02968/2024